Earth Science Tech, Inc.

OTCPK:ETST Stock Report

Market Cap: US$39.2m

Earth Science Tech Valuation

Is ETST undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ETST when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Fair Value: ETST ($0.14) is trading below our estimate of fair value ($0.39)

Significantly Below Fair Value: ETST is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ETST?

Key metric: As ETST is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ETST. This is calculated by dividing ETST's market cap by their current earnings.
What is ETST's PE Ratio?
PE Ratio14.4x
EarningsUS$2.81m
Market CapUS$39.20m

Price to Earnings Ratio vs Peers

How does ETST's PE Ratio compare to its peers?

The above table shows the PE ratio for ETST vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.8x
BSEM BioStem Technologies
3.5xn/aUS$66.0m
BTMD biote
2.8x-52.22%US$112.8m
ZVRA Zevra Therapeutics
15.6x31.38%US$469.5m
ELTP Elite Pharmaceuticals
37.1xn/aUS$527.5m
ETST Earth Science Tech
14.4x84.16%US$39.2m

Price-To-Earnings vs Peers: ETST is good value based on its Price-To-Earnings Ratio (14.4x) compared to the peer average (14.8x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does ETST's PE Ratio compare vs other companies in the US Pharmaceuticals Industry?

8 CompaniesPrice / EarningsEstimated GrowthMarket Cap
NDOI Endo
0.3xn/aUS$1.76b
ORMP Oramed Pharmaceuticals
2.8xn/aUS$117.82m
BTMD biote
2.8x-52.22%US$112.79m
BSEM BioStem Technologies
3.5xn/aUS$66.01m
ETST 14.4xIndustry Avg. 19.6xNo. of Companies8PE01632486480+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ETST is good value based on its Price-To-Earnings Ratio (14.4x) compared to the US Pharmaceuticals industry average (19.6x).

Price to Earnings Ratio vs Fair Ratio

What is ETST's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ETST PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.4x
Fair PE Ratio38.3x

Price-To-Earnings vs Fair Ratio: ETST is good value based on its Price-To-Earnings Ratio (14.4x) compared to the estimated Fair Price-To-Earnings Ratio (38.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

US$1
Fair Value
86.2% undervalued intrinsic discount
1
Number of Analysts

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/06 01:38
End of Day Share Price 2026/01/06 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Earth Science Tech, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sung-Chul KimZacks Small-Cap Research